Filter
614
Text search:
FDA
Featured
Recommendations
81
New Publications
121
Language
Document type
No document type
303
Guidelines
160
Studies & Reports
75
Manuals
24
Fact sheets
24
Strategic & Response Plan
13
Training Material
7
Resource Platforms
3
Brochures
2
Situation Updates
2
Infographics
1
Countries / Regions
India
29
Ghana
17
Latin America and the Carribbean
17
Russia
17
Philippines
12
Myanmar / Burma
12
South Africa
9
Middle East and North Africa
9
USA
8
Kenya
8
Brazil
8
Global
8
Nigeria
7
Congo, Democratic Republic of
7
Germany
7
Syria
7
Argentina
7
West and Central Africa
7
Senegal
6
Uganda
6
Ukraine
6
Colombia
6
Ecuador
6
Yemen
6
Western and Central Europe
6
South Sudan
5
Angola
5
Paraguay
5
Eastern Europe
5
Burkina Faso
4
Liberia
4
Mali
4
Ethiopia
4
Indonesia
4
Mozambique
4
Sudan
4
Peru
4
Eastern Europe and Central Asia
4
Guinea
3
Sierra Leone
3
Nepal
3
Tanzania
3
Thailand
3
Bangladesh
3
Bolivia
3
East and Southern Africa
3
South–East Asia Region
3
Africa
3
Venezuela
3
France
3
Guinea-Bissau
2
Côte d’Ivoire / Ivory Coast
2
Niger
2
Haiti
2
Iraq
2
Jordan
2
Rwanda
2
Namibia
2
El Salvador
2
Chile
2
Asia
2
Albania
2
Tajikistan
2
Morocco
1
Saudi Arabia
1
Cameroon
1
Zimbabwe
1
Somalia
1
Lebanon
1
Egypt
1
Chad
1
Cambodia
1
Mauritania
1
Singapore
1
Malawi
1
Benin
1
Dominican Republic
1
Cuba
1
Honduras
1
Botswana
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Armenia
1
Congo-Brazzaville
1
Qatar
1
Moldova
1
Kazakhstan
1
Tunisia
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
190
Clinical Guidelines
80
Pharmacy & Technologies
22
Women & Child Health
17
Public Health
11
Key Resources
8
Capacity Building
2
Toolboxes
COVID-19
136
Mental Health
69
TB
59
HIV
48
Pharmacy
35
AMR
30
Ebola
28
Rapid Response
17
Specific Hazards
13
NTDs
10
Zika
8
Refugee
7
NCDs
7
Planetary Health
6
Cholera
3
Conflict
3
Natural Hazards
3
Caregiver
3
Global Health Education
2
Disability
1
Introduction
Chapter A.7
Mood disorders
Chapter E.1
2015 edition
Mood disorders
Chapter E.2
Mood disorders
Chapter E.4
2018 edition
Anxiety disorders
Chapter F.1
2018 edition
Anxiety disorders
Chapter F.2
Anxiety disorders
Chapter F.3
Psychiatry and Pediatrics
Chapter I.4
Attention-Deficit/Hyperactivity Disorder
Introducción
Capítulo A.7
Edición en español
Editor: Juan José García-Orozco
Traducción: Juan José García-Orozco y Carlos González Vivas
Revisor de traducción: Laura Borredá Belda
Trastornos del ánimo
Capítulo E.1
Traducción de la versión inglesa del 2015
Trastornos del ánimo
Capítulo E.2
Editores: Matías Irarrázaval & Andres Martin Traductores:
Traducción: Fernanda Prieto-Tagle & Ester Mora
Trastornos des ánimo
Capítulo E.4
Edition 2018
Editores: Matías Irarrázaval & Andres Martin
Traducción: Fernanda Prieto-Tagle & María Vidal
Trastornos de ansiedad
Capítulo F.3
Editores: Laura Revert, Matías Irarrázaval & Andres Martin
Traducción: Régis Villegas, Paula Placencia, José Ángel Alda & Paula Cox
Trastornos de ansiedad
Capítulo F.1
Edición en español
Editor: Matías Irarrázaval
Traducción: Matías Irarrázaval y María Tatiana Estefan
Trastornos de ansiedad
Capítulo F.2
Versión en español:
Editor: Cesar Soutullo
Traductores: Andrea Candelas-Muñoz, Cecilia Hernández-González, Ana Mena
(2015)
Scoping question: Are antidepressants (specifically, tricyclic antidepressants and selective serotonin reuptake inhibitors) effective and safe in adolescents with moderate-severe depressive disorder for whom psychosocial interventions have proven ineffective?